Characterization of cholesterol oxidation products formed by oxidative modification of low density lipoprotein

Free Radical Biology and Medicine

Volumn 23, Issue 2, 1997, Pages 202-214

  Chang, Yi Hsin ^a   Abdalla, Dulcinéia S P ^a   Sevanian, Alex ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cholesterol oxides; Copper; LDL; Lipid peroxidation; Oxidation lag phase; Oxysterol; Vitamin E

Indexed keywords

CHOLESTEROL DERIVATIVE; LOW DENSITY LIPOPROTEIN;

AEROBIC METABOLISM; ARTICLE; CHOLESTEROL METABOLISM; HUMAN; LIPID ANALYSIS; LIPID OXIDATION; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ARTERIOSCLEROSIS; CHOLESTEROL; COPPER; FREE RADICALS; HUMANS; KINETICS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; VITAMIN E;

EID: 0030908862     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00626-0     Document Type: Article

References (66)

1. Van Hinsbergh V., Scheffer M., Havekes L., Kempen H. Role of endothelial cells and their products in the modification of low-density lipoproteins. Biochim. Biophys. Acta. 878:1986;49-64.
2. Henriksen T., Mahoney E., Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. 78:1981;6499-6503.
3. Henriksen T., Mahoney E., Steinberg D. Interactions of plasma lipoproteins with endothelial cells. Ann. NY Acad. Sci. 401:1982;102-116.
4. Henriksen T., Mahoney E., Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis. 3:1983;149-159.
5. Heinecke J. Free radical modification of low density lipoprotein: Mechanisms and biological consequences. Free Radic. Biol. Med. 3:1987;65-73.
6. Berliner J., Heinecke J. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20:1996;707-727.
7. Rajavashisth T., Andalibi A., Teritto M., Berliner J., Navab M., Fogelman A., Lusis A. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulation factors by modified low-density lipoproteins. Nature. 344:1990;254-257.
8. Watson A., Navab M., Hama S., Sevanian A., Prescott S., Stafforini D., McIntyre T., La Du B., Fogelman A. M., Berliner J. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95:1995;774-782.
9. Tertov V., Orekhov A., Sobenin I., Smirnov V. Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein degradation. Circ. Res. 71:1992;218-228.
10. Zhang H., Basra H., Steinbrecher U. Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages. J. Lipid Res. 31:1989;1361-1369.
11. Cathcart M., Morel D., Chisolm G. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J. Leuk. Biol. 38:1985;341-350.
12. Chisolm G., Ma G., Irwin K., Martin L., Gunderson K., Linberg L., Morel D., DiCorleto P. 7β -hydroperoxycholest-5-en- 3β -ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized low density lipoprotein. Proc. Natl. Acad. Sci. 91:1994;11452-11456.
13. Schuh J., Fairclough G., Haschemeyer R. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc. Natl. Acad. Sci. 75:1978;3173-3177.
14. Hodis H., Crawford D., Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis. 89:1991;117-126.
15. Yagi K. Lipid peroxides and human diseases. Chem. Phys. Lipids. 45:1987;337-351.
16. Cazzolato G., Avogaro P., Bittolo-Bon G. Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Radic Biol. Med. 11:1991;247-253.
17. Avogaro P., Bittolo-Bon G., Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis. 8:1988;79-87.
18. Vedie B., Myara I., Pech M., Maziere J., Maziere C., Caprani A., Moatti N. Fractionation of charge-modified low density lipoproteins by fast protein liquid chromatography. J. Lipid Res. 32:1991;1359-1369.
19. Shimano H., Yamada N., Ishibashi S., Mokuno H., Mori N., Gotoda T., Harada K., Akanuma Y., Murase T., Yazaki Y., Takaku F. Oxidation-labile subfraction of human plasma low density lipoprotein isolated by ion-exchange chromatography. J. Lipid Res. 32:1991;763-773.
20. Parthasarathy S., Printz D., Boyd D., Loy L., Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavanger receptor. Arteriosclerosis. 6:1986;505-510.
21. Demuth K., Myara I., Chappey B., Vidie B., Pech-Amsellem M., Haberland M., Moatti N. A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscler. Thromb. Vasc. Biol. 16:1996;773-783.
22. 2+ ions: Identification of major products and their effects. Bioch. Biophys. Res. Com. 176:1991;431-440.
23. -). J. Lipid Res. 35:1994;669-677.
24. Harland W., Gilbert J., Steel G., Brooks C. Lipids of human atheroma. Atherosclerosis. 13:1971;239-246.
25. Yla-Herttuala S., Palinski W., Rosenfeld M., Parthasarathy S., Carew T., Butler S., Witztum J., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions. J. Clin. Invest. 84:1989;1086-1095.
26. Bjorkhem I., Breuer O., Angelin B., Wikstrom S. Assay of unesterified cholesterol-5,6-epoxide in human serum by isotope dilution mass spectrometry. Levels in the healthy state and in hyperlipoproteinemia. J. Lipid Res. 29:1988;1031-1038.
27. Yamamoto Y., Niki E. Presence of cholesteryl ester hydroperoxide in human blood plasma. Bioch. Biophys. Res. Commun. 165:1989;988-993.
28. Esterbauer H., Jurgens G., Quehenberger O., Koller E. Autoxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28:1987;495-509.
29. Hessler J., Morel D., Lewis L., Chisolm G. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 3:1984;215-222.
30. Morel D., DiCorleto P., Chisolm G. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 4:1984;357-364.
31. Hughes H., Mathews B., Lenz M., Guyton J. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associate with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Atherosclerosis. 14:1994;1177-1185.
32. Fong L., Parthasarathy S., Witztum J., Steinberg D. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J. Lipid Res. 28:1987;1466-1477.
33. Peng S., Tham P., Taylor C., Mikkelsom B. Cytotoxicity of cholesterol oxidation derivatives on cultured aortic smooth muscle cells and their effect on cholesterol biosynthesis. Am. J. Clin. Nutri. 32:1979;1033-1042.
34. Imai H., Werthessen T., Subramanyam V., Lequosne P., Soloway A., Kanisawa M. Angiotoxicity of oxygenated sterols and possible precursors. Science. 207:1980;651-653.
35. Peng S., Taylor C., Hill J., Morin R. Cholesterol oxidation derivatives and arterial endothelial damage. Atherosclerosis. 54:1985;121-133.
36. Peng S., Sevanian A., Morin R. Cytotoxicity of cholesterol oxides. Peng S., Morin R. Biological effects of cholesterol oxides. 1992;147-166 CRC Press, Inc, Boca Raton, FL.
37. Sevanian A., Berliner J., Peterson H. Uptake, metabolism, and cytotoxity of isomeric cholesterol-5,6-epoxides in rabbit aortic endothelial cells. J. Lipid Res. 32:1991;147-156.
38. Morin R., Peng S. Effects of cholesterol oxidation derivatives on cholesterol esterifying and cholesteryl ester hydrolytic enzyme activity of cultured rabbit aortic smooth muscle cells. Lipids. 24:1989;217-220.
39. Smith L. The oxidation of cholesterol. Peng S., Morin R. Biological effects of cholesterol oxides. 1992;7-32 CRC Press, Inc, Boca Raton, FL.
40. Nourooz-Zadeh J. Cholesterol autoxidation. Nourooz-Zadeh J. Cholesterol oxides in food. 1988;9-11 Uppsala.
41. Smith L. Subsequent Transformations. Smith L. Cholesterol autoxidation. 1981;201-242 Plenum Press, New York, NY.
42. Imai H., Werthessen T., Taylor C., Lee K. Angiotoxicity and atherosclerosis due to contaminants of USP grade cholesterol. Arch. Pathol. Lab. Med. 100:1976;565-569.
43. Sevanian A, Hodis H, Hwang J, Peterson H. Bellomo G, Finardi G, Maggi E, Rice-Evans C. Involvement of cholesterol oxides in the atherogenic action of oxidized LDL. 1995;Richelieu Press, London.
44. Corongiu F., Banni S., Dessi M. Conjugated dienes detected in tissue lipidextracts by second derivative spectroscopy. Free Radic. Biol. Med. 7:1989;183-186.
45. Lowry O., Rosebrough N., Farr L., Randall R. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
46. -) with dense LDL subpopulations and its contribution to LDL oxidation. Arterioscleros. Thrombos. 16:1996;784-793.
47. Esterbauer H., Rotheneder M., Strirgl G., Waeg G., Ashy A., Sattler W., Jurgens G. Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat. Sci. Technol. 91:1989;316-324.
48. Sevanian A., Seraglia R., Traldi P., Rossato P., Ursini F., Hodis H. Analytical approaches to the measurement of plasma cholesterol oxidation products using gas and high performance liquid chromatography/mass spectrometry. Free Radic. Biol. Med. 17:1994;397-410.
49. Hodis H., Crawford D., Sevanian A. Identification and quantification of cholesterol oxides in normocholesterolemic and cholesterol-fed hypercholesterolemic New Zealand white rabbit plasma. Arteriosclerosis. 89:1991;117-126.
50. Sevanian A., Stein R., Mead J. Epoxides as products of lipid autoxidation in rat lungs. Lipids. 14:1979;634-643.
51. Bieri J., Tolliver T., Catignani G. Simultaneous determination of α -tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am. J. Clin. Nutr. 32:1979;2143-2149.
52. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
53. Theunissen J., Jackson R., Kempen H., Demel R. Membrane properties of oxysterols. Interfacial orientation, influence on membrane permeability and redistribution between membranes. Biochim. Biophys. Acta. 860:1986;66-74.
54. Bowry V., Stanley K., Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. 89:1992;10316-10320.
55. Smith L. Cholesterol Oxidation. Vigo-Pelfrey C. Membrane lipid oxidation. 1990;129-154 CRC Press, Inc, Boca Raton, FL.
56. Brown A., Dean R., Jessup W. Free and esterified oxysterol: Formation during copper-oxidation of LDL and uptake by macrophages. J. Lipid Res. 37:1996;320-335.
57. Keri L. Production of oxidized lipids during modification of LDL by magrophages or copper. Biochem. J. 304:1994;625-633.
58. Smith L. Another cholesterol hypothesis: cholesterol as antioxidant. Free Radic. Biol. Med. 11:1991;47-61.
59. 2+ and ascorbic acid induced oxidation of cholesterol in phosphatidylcholine liposomes and its inhibition by α -tocopherol. J. Nutr. Sci. Vitaminol. 31:1985;499-508.
60. Lercker G., Capella P., Conte L. Thermal decomposition of methyl oleate hydroperoxides. La Rivista Italiana Delle Sostanze Grasse. 61:1984;623-627.
61. Sevanian A., McLeod L. Cholesterol autoxidation in phospholipid membrane bilayers. Lipids. 22:1987;627-636.
62. Steinbrecher U., Parthasarathy S., Leake D., Witztum J., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. 81:1984;3883-3887.
63. Carpenter K., Wilkins G., Fussel B., Ballantine J., Taylor S., Mitchinson M., Leake D. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. Biochem. J. 304:1994;625-633.
64. Nagelkerke J., Havekes L., Van Hinsbergh V., Van Berkel T. In vivo catabolism of biologically modified LDL. Arteriosclerosis. 4:1984;256-264.
65. Dzeletovic S., Babiker A., Lund E., Diczfaluzy U. Time course of oxysterol formation during in vitro oxidation of low density lipoprotein. Chem. Phys. Lipids. 78:1995;119-128.
66. Kritharides L., Jessup W., Mandor E., Dean R. Apolipoprotein A-1-mediated efflux os sterols from oxidized LDL-loaded macrophages. Arterioscler. Thromb. Vasc. Biol. 15:1995;276-289.